Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Inventory (2016 - 2025)

Historic Inventory for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $20.3 million.

  • Veracyte's Inventory fell 18.17% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year decrease of 18.17%. This contributed to the annual value of $21.8 million for FY2024, which is 3485.86% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Inventory is $20.3 million, which was down 18.17% from $25.0 million recorded in Q2 2025.
  • Veracyte's Inventory's 5-year high stood at $25.0 million during Q2 2025, with a 5-year trough of $6.3 million in Q1 2021.
  • Over the past 5 years, Veracyte's median Inventory value was $14.6 million (recorded in 2022), while the average stood at $15.5 million.
  • Per our database at Business Quant, Veracyte's Inventory surged by 14103.5% in 2021 and then crashed by 2073.97% in 2023.
  • Veracyte's Inventory (Quarter) stood at $11.2 million in 2021, then grew by 27.34% to $14.3 million in 2022, then increased by 12.83% to $16.1 million in 2023, then skyrocketed by 34.86% to $21.8 million in 2024, then dropped by 6.54% to $20.3 million in 2025.
  • Its Inventory stands at $20.3 million for Q3 2025, versus $25.0 million for Q2 2025 and $24.3 million for Q1 2025.